Comparison of morbidity and mortality after radical cystectomy between individuals older and younger than 80 years: a systematic review and meta-analysis

W Zhu, L Wu, W Xie, G Zhang, Y Gu, Y Hou… - International Urology and …, 2024 - Springer
Objective To compare outcomes related to survival and post-operative complications in
individuals older and younger than 80 years with bladder cancer undergoing radical …

Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker

R Ben-David, R Mehrazin, K Attalla… - Current Opinion in …, 2024 - journals.lww.com
The integration of ctDNA in clinical decision-making has the potential to revolutionize the
way we manage urothelial carcinoma by refining patient selection to different treatment …

Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Markov microsimulation model

D Magee, D Cheung, A Hird, SS Sridhar… - Canadian …, 2021 - pmc.ncbi.nlm.nih.gov
Introduction Radical cystectomy (RC) is the historic gold standard treatment for muscle-
invasive bladder cancer (MIBC), but trimodal therapy (TMT) has emerged as a valid …

Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis

R Ben-David, F Pellegrino, P Alerasool, N Tillu… - World Journal of …, 2024 - Springer
Background Robotic-assisted radical cystectomy (RARC) offers decreased blood loss during
surgery, shorter hospital length of stay, and lower risk for thromboembolic events without …

[HTML][HTML] Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients

Z Savin, L Levin, A Lazarovich, B Rosenzweig… - Journal of Personalized …, 2024 - mdpi.com
Introduction: Current guidelines endorse the use of perioperative chemotherapy (POC) in
muscle-invasive bladder cancer (MIBC) to enhance the long-term overall survival (OS) …

11-item modified frailty index and outcomes after radical cystectomy

Z Savin, O Yossepowitch, A Lazarovich… - Journal of Geriatric …, 2023 - Elsevier
Introduction To investigate the association between modified frailty index (mFI) scores and
radical cystectomy outcomes. Materials and Methods We conducted a multicenter …

[PDF][PDF] ПРЕИМУЩЕСТВА ЭКСТРАПЕРИТОНЕАЛЬНОЙ РАДИКАЛЬНОЙ ЦИСТЭКТОМИИ В ЛЕЧЕНИИ БОЛЬНЫХ С ИНВАЗИВНЫМ РАКОМ МОЧЕВОГО …

МИ Болтаев, ЖМ Искандаров - Академические исследования в …, 2024 - econferences.ru
ПРЕИМУЩЕСТВА ЭКСТРАПЕРИТОНЕАЛЬНОЙ РАДИКАЛЬНОЙ ЦИСТЭКТОМИИ В ЛЕЧЕНИ
Page 1 ACADEMIC RESEARCH IN MODERN SCIENCE International scientific-online conference …

ОЦЕНКА ПОСЛЕОПЕРАЦИОННЫХ ОСЛОЖНЕНИЙ ТРАНСПЕРИТОНЕАЛЬННОЙ РАДИКАЛЬНОЙ ЦИСТЭКТОМИИ

МИ Болтаев, ЖМ Искандаров - Академические исследования в …, 2024 - econferences.ru
Аннотация Периодический мониторинг результатов радикальной цистэктомии с
учетом частоты и характера хирургических осложнений представляет определенный …

Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer

R Ben-David, MD Galsky, JP Sfakianos - Trends in Molecular Medicine, 2024 - cell.com
The pursuit of surgeons and oncologists in fulfilling the inherent desire of patients to retain
their urinary bladder despite having muscle-invasive bladder cancer (MIBC) has sparked …

[引用][C] Comparative Characteristics of the Direct Results of Extraperitoneal and Transperitoneal Access in the Surgical Treatment of Bladder Cancer

T Mirzagaleb, B Mashrabjon, R Nodir, I Iroda - Annals of the Romanian Society for …, 2021